Critical Path Institute - The Path Forward in Drug Development
C-Path (Critical Path Institute) optimizes drug and medical product development lifecycles by convening pharma, government, patient and academic organizations.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-02 | 6.614 |
| 2025-03 | 8.274 |
| 2025-04 | 8.891 |
| Source | Traffic Share |
|---|---|
| search | 43.93% |
| direct | 40.78% |
| referrals | 7.18% |
| social | 6.91% |
| paid referrals | 1.03% |
| 0.09% |
| Region | Percentage |
|---|---|
| United States | 61.65% |
| India | 13.38% |
| Canada | 8.92% |
| Germany | 8.30% |
| FR | 4.59% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| critical path institute | 42 | 420 | $0.00 |
| transplant therapeutics consortium | 0 | 0 | $0.00 |
| how do you validate a biomarker biomarker qualification plan | 4 | 40 | $0.00 |
| safety and tolerability study | 11 | 110 | $0.00 |
| 2025 crmc annual clinical mandatories review due on thursday, april 17, 2025 11:59 pm et | 0 | 0 | $0.00 |